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Abstract – A number of virologic and environmental factors are involved in the emergence and
re-emergence of viral disease. Viruses do not conservatively occupy a single and permanent ecological
niche. Rather, due to their intrinsic capacity for genetic change, and to the evolvability of ﬁtness levels,
viruses display a potential to parasitize alternative host species. Mutation, recombination and genome
segment reassortment, and combination of these molecular events, produce complex and phenotypically
diverse populations of viruses, which constitute the raw material on which selection acts. The majority of
emerging viral diseases of humans have a zoonotic origin. Sociologic and ecologic factors produce diverse
and changing environments in which viral subpopulations have ample opportunities to be selected from
intrinsically heterogeneous viral populations, particularly in the case of RNA viruses. In this manner, new
human, animal and plant viruses have emerged periodically and, from all evidence, will continue to emerge.
This article reviews some of the mechanisms that have been identiﬁed in viral emergence, with a focus on
the importance of genetic variation of viruses, and on the general concept of biological complexity.
mutation / recombination / reassortment / quasispecies / virus adaptation
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1. INTRODUCTION
Very few topics in Virology relate so closely
to the general concept of biological complexity
as the emergence and re-emergence of viral
disease. In the introduction to their classic
book, Sole´ and Goodwin deﬁne the sciences
of complexity as ‘‘the study of those systems
in which there is no simple and predictable
relationship between levels, between the prop-
erties of parts and of wholes’’ [78]. The emer-
gence of viral disease involves several levels
of complexity. The underlying level stems from
the population structure of viral populations as
they replicate in their standard hosts. Model
studies of plaque-to-plaque transfers (bottleneck* Corresponding author: edomingo@cbm.uam.es
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Figure 1. Schematic representation of genomic variations and population dynamics of RNA viruses. (A) In
infected hosts RNA viruses replicate as complex distributions of related genomes termed viral quasispecies.
Here two out of multiple distributions are represented. Horizontal lines depict individual genomes and
symbols on the lines represent different mutation types (transitions, transversions and short insertions or
deletions termed indels). A distribution is deﬁned by a consensus sequence and a mutant spectrum with a
complexity given by the average pairwise genetic (also termed Hamming) distance among its components
or the average mutation frequency. (B) Molecular recombination. (C) Genome segment reassortment, using
inﬂuenza A virus (eight genomic segments) as an example. Reassortment (in this case the replacement of
HA and NA genes) gives rise to an antigenic shift. Continued accumulation of mutations results in gradual
antigenic drift. (D) A simpliﬁed view of quasispecies dynamics and ﬁtness change. Unrestricted replication
(large black arrow-head on the right, with multiple passages indicated by the dotted line) results in ﬁtness
gain, as depicted by the triangle at the bottom. Fitness gain can occur without variation of the consensus
sequence (top). In contrast, repeated bottleneck transfers (left, with the dotted line representing multiple
transfers) result in accumulation of mutations that modify the consensus sequences, and in ﬁtness decrease.
At low and high ﬁtness values signiﬁcant ﬂuctuations of ﬁtness values have been observed. This ﬁgure is
based on previously published data and concepts [4, 9, 11–14, 16, 17, 19, 21, 25, 29, 31, 35, 41, 57, 59–61,
66, 71, 74].
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passages) of foot-and-mouth disease virus
(FMDV) in BHK-21 cells (Fig. 1) showed that
the pattern of ﬁtness decay of the virus followed
a Weibull distribution [42]. This type of statisti-
cal distribution suggests that the mutations ﬁxed
in the viral genome at each transfer produced a
cascade of perturbations in the virus-host inter-
actions that were sensed in the form of a change
in virus yield [42]. The unpredictability of the
effect of mutations is further reinforced by the
increasing evidence that viral proteins are
multi-functional so that mutations can alter
one or more of the interactions between viral
and host components that determine the viral
yield per cell [42].
The second level of complexity results from
a network of environmental, ecologic, and
sociologic inﬂuences that affect the probability
that a potentially pathogenic virus comes into
contact with a new host. A good number of
such inﬂuences are subjected to indetermina-
tion. To give a speciﬁc example, a change in
temperature and humidity in a large geographi-
cal area may alter ﬂora and fauna, and, as a
result, the distribution of viral vectors (arthro-
pods, birds, mammals). However, which vec-
tors and how they will be affected by weather
or climate conditions are usually difﬁcult to pre-
dict since they depend on sets of ecological
interactions. Finally, another level of complex-
ity intervenes in the epidemiological outcome
of a viral disease, once it has emerged. Severe
acute respiratory syndrome (SARS) faded
months after its emergence, while Acquired
Immune Deﬁciency Syndrome (AIDS) has
become a severe pandemics, to last for many
decades or forever. The difference can be attrib-
uted to the pattern of virus-host interaction and
the capacity of the virus to be transmitted from
an infected host individual into a susceptible
individual. Again, these processes fall into the
domain of biological complexity. Advances in
molecular virology and the development of
computational tools for viral surveillance have
greatly improved our knowledge of the factors
that underlie the emergence and re-emergence
of viral disease, and, interestingly and paradox-
ically, we understand some of the reasons
behind the unpredictability of emergences.
2. BASIC FEATURES OF VIRUSES
AT THE POPULATION LEVEL. FITNESS
Viral disease emergence is a major concern
in public health, and the events behind their
occurrence have been extensively analyzed
[1, 33, 55, 69, 77]. Although in most published
accounts on viral disease emergence the role of
genetic variation of viruses has been consid-
ered, the majority of studies have examined fac-
tors that affect viral trafﬁc, and have described
many examples of inter-species transmissions.
Few treatments have dissected intra-host
genetic variation of viruses as a key element
in virus adaptability and, therefore, in virus dis-
ease emergence.
Viral emergences and re-emergences can be
regarded as episodes of virus adaptation to a
new environment. Adaptation can be measured
as an increase of replicative ﬁtness, deﬁned as
the capacity of a virus to produce infectious
progeny in a given environment [11, 14, 71].
The term epidemiologic ﬁtness describes in
semiquantitative ways (for example, through
diagnostic surveys, by sampling nucleotide
sequences of viruses that compete in a given
geographical area, etc.) the capacity of a virus
(a serotype, clade or variant) to become domi-
nant, relative to other serotypes, clades or vari-
ants of the same virus [14]. For example, a
FMDVof serotype O termed FMDV O PanAsia
was ﬁrst isolated in India in 1990 and then, in
the following years, the virus spread to several
countries. FMDV PanAsia manifested high epi-
demiologic ﬁtness, since it displaced other
FMDV strains that circulated at that time in
the same geographical areas [39]. A more
recent example is provided by the new H1N1
human inﬂuenza virus that originated in swine,
crossed the species barrier into the human pop-
ulation early in 2009, and is currently displac-
ing the H1N1 and H3N1 viruses that were
dominant at the time of irruption of the new
H1N1 [74]. Replicative ﬁtness is a relevant con-
cept in evolutionary biology in general, and it
has become very important to quantitate virus
adaptability in numerous scenarios, including
clinical and diagnostic virology (as reviews,
see [11, 14, 71]) (Fig. 1).
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What are the molecular mechanisms under-
lying ﬁtness changes in viral populations?
Many studies with human, animal and plant
viruses suggest that ﬁtness variations are associ-
ated with genetic change, mediated by muta-
tion, recombination and genome segment
reassortment during viral replication (Fig. 1).
Mutation is a universal mechanism of genetic
variation that affects all viruses, while recombi-
nation appears to vary greatly in frequency
among different viruses. Segment reassortment
is obviously restricted to viruses with seg-
mented genomes. It must be emphasized that
ﬁtness values, as well as the ﬁtness effects of
genetic variation, are dependent on the
sequence context of a viral genome and on
the physical and biological environments in
which the virus replication capacity is tested.
Next I discuss how genetic change underlies ﬁt-
ness variations and how such variations unpre-
dictably affect the adaptation of viruses to new
environments.
3. BIOLOGICAL IMPLICATIONS
OF MUTATION, RECOMBINATION
AND REASSORTMENT. QUASISPECIES
AS RAW GENOMIC DISTRIBUTIONS
FOR SELECTION OF VIRAL
SUBPOPULATIONS
Viruses can be divided into those that have
DNA and those that have RNA as genetic mate-
rial. Relevant with regard to the occurrence of
mutations during viral genome replication is
the distinction among four replicative schemes
that can be schematically described as follows:
1. DNA ! DNA ! DNA
2. DNA ! RNA ! DNA
3. RNA ! RNA ! RNA
4. RNA ! DNA ! RNA
The nucleic acid written in the ﬁrst and third
place in each of the four schemes is the one
found in the parental and progeny viral parti-
cles. The nucleic acid in the middle position
indicates the type of nucleic acid that acts as
replicative intermediate (not the transcripts
involved in gene expression that participate in
the infectious cycle). The presence or not of
RNA in the scheme determines the potential
of genetic variation of the virus. RNA viruses
and DNA viruses that have RNA as replicative
intermediate (that is, viruses that follow replica-
tive schemes 2, 3 and 4) display elevated muta-
tion rates that have been estimated in 103 to
105 misincorporations per nucleotide copied
[4, 14, 17]. The molecular basis for high muta-
tion rates is the absence of a proofreading-repair
activity in the viral RNA-dependent RNA poly-
merases (RdRp) and RNA-dependent DNA
polymerases (RdDp) (also termed reverse tran-
scriptases (RT)), evidenced by functional and
structural studies [24, 52, 79]. There appear to
be some exceptions to this rule, as suggested
by the capacity of the inﬂuenza virus polymer-
ase to remove excess GMP residues added to a
capped oligonucleotide primer [37], a 30-end
repair mechanism described in a satellite RNA
of a plant virus [56], and a 30-50 exonuclease
activity encoded by some coronaviruses
[18, 54]. However, it has not been established
whether the decrease in mutation rate promoted
by such mechanisms has a major consequence
for the biology of the corresponding viruses. In
addition to the general absence of proofreading-
repair activities in RdRps and RdDps, the cellu-
lar post-replicative-repair pathways that act to
correct mismatches in double-stranded DNA
are not effective in repairing either double-
stranded RNA or RNA-DNA hydrids [26].
Lack of proofreading-repair and post-replicative
repair activities contributes decisively to high
mutation rates of riboviruses, retroviruses and
hepadnaviruses, a feature that has a profound
inﬂuence in their biology [14].
DNAviruseswith largegenomes (poxviruses,
iridoviruses, adenoviruses) encode DNA poly-
merases endowed with a proofreading 30-50 exo-
nuclease activity, similar to those found in
cellular, replicative DNA-dependent DNA
polymerases (DdDp). Therefore, such DNA
viruses are not expected to display the general
high mutation rates typical of RNA viruses.
However, it would be important to measure
mutation rates for DNAviruses in order to com-
pare the values with those available for RNA
viruses. Relevant factors that can inﬂuence the
mutation rates displayed by DNA viruses are
Vet. Res. (2010) 41:38 E. Domingo
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whether the viral genome DNA is replicated by
a high or low ﬁdelity DNA polymerase, and
whether post-replicative repair pathways reach
the viral replication sites, and can cope with
the correction of errors that may occur in many
nascent DNA genomes in viral replication com-
plexes where viral DNA accumulates. These
questions have not been solved [14].
High mutation rates of RNA viruses and
some DNA viruses result in dynamic distribu-
tions of mutants termed viral quasispecies
(Fig. 1). Viral quasispecies constitute reservoirs
of genetic and phenotypic variants, with several
biological implications for viral evolution and
pathogenesis, some of which have become
apparent over the last few years (reviews in
[13, 14, 16, 25]) (Tab. I). The main conceptual
extension that quasispecies has represented for
RNA virus genetics is that the ‘‘wild type’’
can no longer be assigned to a speciﬁc genomic
nucleotide sequence but to a distribution of
sequences. Mutation is not an occasional event
but a continuously occurring event. When the
consensus sequence is seen as invariant it is
not because mutations did not occur but
because they occurred in components of mutant
spectrum without a change in the average or
consensus sequence (Fig. 1). This is a key
departure from classic genetics, and one of the
fuels for viral disease emergences, since viral
quasispecies may provide viral subpopulations
ready to be selected in response to an environ-
mental change, for example, an alternative host.
As discussed below, the multi-phenotypic
potential inherent to viral quasispecies repre-
sents a major driving force for viral disease
emergence. In some cases, however a mutation
reﬂected in the consensus (epidemic VEEV
ampliﬁcation in horses, expansion of inﬂuenza
host range, etc.) may also serve as determinant
of an emergence.
Recombination occurs both with RNA and
DNA viruses, but it is infrequent with most
negative-strand RNA viruses. Recombination
has been divided in replicative and non-replica-
tive, according to whether viral genome replica-
tion is required or not [9, 29]. From the point of
view of evolution, recombination has been
viewed as a means to rescue ﬁt viral genomes
from low ﬁtness parents (a force to eliminate
deleterious mutations) or a means to produce
highly divergent genomes that provide an
opportunity to explore the adaptative potential
of rare genomic combinations (a force for large
evolutionary transitions). There is good evi-
dence that recombination and reassortment
events, followed by ﬁtness adjustments through
mutation, have played a role in the emer-
gence and re-emergence of new viral patho-
gens. In fact, most (but not all) emergences
Table I. Some biological implications of the quasispecies nature of RNA viruses.
1. Viral genomes are collections of mutant genomes termed mutant spectra or mutant clouds. Mutant clouds may
include phenotypic variants adequate to respond to selective constraints (antibody- and cytotoxic T cell-escape
mutants, inhibitor- or mutagen-resistant mutants; cell tropism and host-range mutants, etc.). The phenotypic
repertoire of a viral quasispecies can contribute to viral persistence, pathogenesis and to the limited efﬁcacy
of treatments designed to limit viral replication.
2. Viral quasispecies can include memory genomes as minority components of their mutant spectra. Memory
provides an adaptive advantage to viral populations.
3. Mutant spectra are not merely collections of mutant viruses acting independently. Positive interactions (of
complementation) or negative interactions (of interference) can be established within mutant spectra. Thus
viral quasispecies act as a unit of selection and cannot be accurately described by classical Wright-Fisher
formulations of population genetics.
4. The understanding of quasispecies dynamics has helped deﬁning protocols for preventive and therapeutic
designs (vaccines to control viral quasispecies must be multivalent, antiviral agents must be sued in com-
bination) and has impelled new antiviral strategies such as lethal mutagenesis (virus extinction by excess
mutations).
Based in references [2, 3, 6, 8, 11–16, 19, 25, 34, 36, 49, 58, 59].
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and re-emergences of human viral diseases, that
have amounted to about one per year during the
last decades, have been associated with RNA
viruses that display active recombination or
reassortment. As examples, several recent
poliomyelitis outbreaks have been related to
viruses generated by recombination between
attenuated vaccine polioviruses and other circu-
lating enteroviruses [75]. As an historical event,
the coronavirus mouse hepatitis virus appears to
have acquired its hemagglutinin-esterase gene
by recombination with an inﬂuenza type C
virus [46]. Also, the alphavirus Western equine
encephalitis virus probably resulted from an
ancient recombination between a Sindbis-like
and a Easter-equine encephalitis-like virus
(reviewed in [87]). The emergence of the SARS
coronavirus around 2002 probably involved the
transfer of the virus from a bat to a carnivore
(probably a civet cat); contact with civets may
have facilitated the human outbreak. The
human ACE2 receptor-binding sequences used
by the human SARS coronavirus may have
been acquired by recombination with a preex-
isting group 1 human coronavirus [45]. In this,
and in the other cases in which recombination
played a role in the generation of a new patho-
gen, selection of virus variants for a more efﬁ-
cient replication in the new host (for receptor
use or other) probably took place [91].
Genome segment reassortment is a major
evolutionary force for some viruses with a seg-
mented genome, the most studied case being re-
assortments in the inﬂuenza type A viruses.
Reassortants that have acquired the hemaggluti-
nin and/or neuraminidase genes from viruses of
some animal reservoirs (notably birds or swine)
have been associated with the major human
inﬂuenza pandemics such as the Spanish inﬂu-
enza of 1918 (H1N1 virus), the Hong Kong
inﬂuenza of 1968 (H3N2 virus) or the pandem-
ics of 2009 (H1N1 virus) [35, 66, 74]. Such
viruses acquired a selective advantage relative
to previously circulating inﬂuenza viruses
because the new hemagglutinin and/or neur-
aminidase surface antigens were not recog-
nized (or were only poorly recognized) by the
neutralizing antibodies present in the human
population. The acquisition of new genome
segments that produce a change in antigenic
speciﬁcity is termed antigenic shift. The gradual
antigenic modiﬁcation undergone by the virus
as it circulates in the human population is
termed antigenic drift. The latter is linked to
point mutations that affect the antigenic deter-
minants, and can be regarded as the ﬁtness
adjustment by mutation as the virus explores
new environments (some of which include
anti-inﬂuenza antibodies) following a reassort-
ment event. Drastic and gradual versions of
antigenic variation are not exclusive of inﬂu-
enza virus, and they have been amply recog-
nized as a major factor in the adaptation of
viruses to host organisms endowed with an
immune system [48, 67]. Viruses are undoubt-
edly subjected to selective constraints additional
to the several components of an immune
response, and some of them probably have
not even been identiﬁed. Multiple constraints
contribute to shape the genomic compositions
of the viral populations as they complete suc-
cessive life cycles. Mutation, recombination
and reassortment can produce new viral forms,
a minority of which might be competent to rep-
licate in a new environment. There is evidence
that a true recombinant hemagglutinin might
have been one of the virulence determinants
of the inﬂuenza pandemics of 1918 [28].
The mechanisms of genetic variation of
viruses are blind forces (mutation, recombina-
tion and gene transfer events) that have acted
historically to build the biosphere we know,
under the guidance of natural selection. Eigen
and Biebricher adapted the concept of sequence
space, originally formulated by Maynard Smith
for proteins [50], to describe all the possible
nucleotide sequences that a given replicating
entity can have [19]. The theoretical sequence
space of any organism or any virus is huge
(4n), being n the number of genomic nucleo-
tides. Only a minute portion of the theoretical
sequence space is compatible with virus infec-
tivity and survival. Mutation prompts explora-
tion of neighbor sites in sequence space,
while recombination offers the possibility to
explore distant sites in sequence space. Non-
homologous recombination events (that is,
those that occur between genomes or genomic
sites that do not show nucleotide sequence iden-
tity) constitute a means to promote exchanges
Vet. Res. (2010) 41:38 E. Domingo
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of genetic material among organisms that
belong to distant phyla, including exchanges
between viruses and cells. Recent developments
in genomics are unveiling surprising relation-
ships among very distant organisms, giving rise
to a tree of life with inter-kingdom connections
due to lateral gene transfers, that were unsus-
pected just a few decades ago [7].
Interestingly, despite the obvious impact of
recombination for viral evolution [14, 41, 57],
some negative-strand RNA viruses do not seem
to display an active recombination, at least
among standard infectious genomes. These
viruses show, however, an extremely high adap-
tive potential comparable to that of other RNA
viruses that display an active recombination
[61]. This suggests that the viruses that have
survived to the present time, and probably also
their ancestors, have redundant adaptive mech-
anisms to respond to the multiple selective con-
straints that their hosts have evolved to limit
their replication. All mechanisms of genetic
variation of viruses exert a key inﬂuence in viral
disease emergence, as discussed next.
4. STEPS IN VIRAL DISEASE EMERGENCE
AND THE ROLE OF VIRAL VARIATION
Aviral emergence is generally deﬁned as the
appearance of a new pathogen for a host, such
as human immunideﬁciency virus (HIV)-1 for
humans in the twentieth century. Viral re-emer-
gence often refers to the reappearance of a viral
pathogen after a period of absence, such as the
periodic human inﬂuenza epidemics or pan-
demics. Three major steps have been distin-
guished in the processes of viral disease
emergence or re-emergence: (1) introduction
of a viral pathogen into a new host species,
(2) establishment of the pathogen in the new
host, and (3) dissemination of the pathogen
among a large number of individuals of
the new host species to bring about outbreaks,
epidemics or pandemics. Viral genome adapt-
ability has been listed as one of 13 major inﬂu-
ences that determine the emergence of
infectious disease [1, 55, 69, 77]. The inﬂu-
ences cited by Smolinski et al. include modiﬁ-
cations of climate, weather and ecosystems,
human demographics and behavior, interna-
tional travel and commerce, poverty, social
inequality, war and famine, and lack of political
will. Peters has emphasized the role of viral var-
iation by expressing viral emergence in the fol-
lowing terms: (viral variation) + (changing
ecology) + (travel and transport) = (increased
opportunities for viral emergence) [69].
It is not easy to specify at which stage of an
emergence or re-emergence process virus varia-
tion plays a role and to what extent virus vari-
ation is essential or accessory. However, the
presently available evidence suggests that viral
genome variation participates in each of the
processes that culminate in dissemination of
the viral pathogen among individuals of the
newly colonized host. Concerning the introduc-
tion step, current knowledge of viral population
dynamics and of virus-host interactions sug-
gests that chance encounters between viruses
and potential new hosts must occur frequently.
Consider the many areas of the world in which
humans have regular contacts with animals or
vectors that carry viruses (farm animals, mos-
quitoes, etc.) [89]. Most likely, only a tiny
minority of such chance encounters gives rise
to an emergence or re-emergence of a viral
disease.
Regarding the role of genetic variation, there
are several possibilities to explain a successful
introduction of a virus into a new host species.
The main ones are: (1) the virus is competent to
replicate equally well in the donor host species
and in the recipient new host species. No
genetic variation for the change of host range
is needed. The reason why the emergence did
not occur before is that either the encounter
between the two hosts had not occurred until
then, or that a threshold dose of virus needed
for the successful introduction had not been
attained in past encounters. Such a threshold
amount of virus can be imposed by limited
virus particle stability, the immune response of
the recipient host, and other factors. (2) The
virus is not efﬁcient in replicating in the new
host, and genetic variation of the virus must
intervene to achieve a successful introduction.
In this case, again, several factors come into
play. They are brieﬂy described here solely
to emphasize the complex and unpredictable
Mechanisms of viral emergence Vet. Res. (2010) 41:38
(page number not for citation purpose) Page 7 of 14
nature of a successful introduction step. Muta-
genesis is a highly stochastic event subject to
the quantum-mechanic uncertainties associ-
ated with formation of infrequent tautomeric
forms, or other alterations of nucleotides that
contribute to misincorporation events [5, 26].
Although in RNA virus genetics it is often con-
sidered that mutation rates are high enough not
to be the limiting factor for adaptability, there is
a caveat in this argument when applied to a dis-
ease emergence that requires modiﬁcation of
the host range of a virus. In general, the gener-
ation of a speciﬁc mutant type will not be a lim-
iting factor provided that: (i) the standard
mutation rates that have been measured for
RNA viruses operate [4, 14, 17] (discussed in
the previous section), (ii) the population size
of the replicating virus is sufﬁciently large,
and (iii) that once the required mutation has
occurred, the mutant virus maintains a sufﬁcient
ﬁtness level, in the context of the surrounding
mutant spectrum. However, a natural chance
contact between an infected donor host and a
potential recipient of another host species is
unlikely to involve a large viral population size.
Under such conditions, the occurrence of the
mutations required for a change in host range
may become a limiting factor for the introduc-
tion phase of disease emergence. In some
designed experiments of adaptation of a virus
in a new host species it has been shown than
an initial inefﬁcient replication in a recipient
host is followed by ﬁtness increase mediated
by point mutations that occurred gradually in
the mutant spectrum of the viral quasispecies
evolving in vivo [64]. The barriers imposed
by the host to a new viral pathogen may render
establishment unlikely. The required viral
genetic change must lie within the range
achievable by mutation, recombination or reas-
sortment (or their combinations) in the given
environmental context.
Once established, additional adaptive muta-
tions are likely to occur while the virus com-
pletes its infectious cycle in the target cells
and organs of the newly invaded host. There
have been many descriptions that viruses repli-
cating either in cell culture or in vivo, when
given the opportunity, increase their replicative
ﬁtness [21, 59, 60]. Fitness increase is the
expected response when a virus maintains
replicative competence in a new environment,
or when it escapes from natural (neutralizing
antibodies or cytotoxic T cells) or artiﬁcial
(antiviral drug) selective pressures (reviewed
in different chapters of [12, 13, 16]). In vivo
an ‘‘arms race’’ is established between the virus
and the host: the virus increases its ﬁtness but it
must overcome the multiple physiological
responses intended to limit virus replication
and to clear the virus from the organism. Suc-
cessful evasion contributes to viral persistence,
as documented with different viral pathogens
[6, 8, 13, 15, 49] (Tab. I).
Virus dissemination in a new host species
occurs when the viral ﬁtness in the recipient
host is such that transmission from one infected
individual into susceptible individuals of the
same species attains a minimum required value.
Here, again, several interconnected factors can
play a role: the viral load achieved in the
infected donor, the amount of infectious parti-
cles shed by the donor, the amount of virus in
the different secretions and excretions (saliva,
blood, semen, feces, etc.), transmission routes
(contact, aerosol, blood, sexual, etc.) [22, 53],
the stability of the virus particles, etc. Thus,
many inﬂuences that depend on the genetic
make up of the virus and also on the nature
of the virus-host relationship affect virus trans-
missibility. The capacity of expansion in the
new host species is often expressed by a repro-
ductive ratio of R0 > 1, that quantitates the
average number of infected contacts produced
by each infected host [62, 63]. Some viruses,
such as the SARS coronavirus, did not reach
an average R0 > 1 once introduced in the
human population, preventing their continued
expansion. Because of its epidemiologic param-
eters, SARS could be controlled by public
health measures. In contrast, other viruses such
as HIV-1 or the rhinoviruses are, unfortunately,
highly efﬁcient in sustained human-to-human
transmission. In the case of HIV-1, asymptom-
atic donor individuals are capable of transmit-
ting the virus to multiple recipient individuals
[44]. In this case, a change of social habits
(including sexual promiscuity, and travel)
have contributed to the dissemination of HIV-1
in the human population. Obviously R0 is not
Vet. Res. (2010) 41:38 E. Domingo
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invariant, and may be modiﬁed by genetic
change of the virus.
The number of infectious particles shed by
each infected individual is critical not only
because the amount of virus that is shed affects
the probability of encountering a susceptible
host, but also because the larger the number
of infectious particles the broader the spectrum
of mutants that will reach the recipient host
individuals (Fig. 2). Viral population numbers
can be largely ampliﬁed in immunocompro-
mised individuals, that have been termed
‘‘super-shedders’’ or ‘‘super-spreaders’’, and
constitute large reservoirs of variant viruses
[27, 38, 65, 68, 72, 76].
A biological feature relevant to emergence is
the overlap that has been identiﬁed in several
viruses between receptor-recognition sites and
antigenic sites. The fact that some exposed
amino acid residues are part of one or several
epitopes for antibody binding, as well as part
of the receptor-recognition domain, may favor
the coevolution of host cell tropism and antige-
nicity [2, 3, 36, 58, 83]. Such overlap is, how-
ever, double-edged. It opens the possibility of
pleiotropic effects of single mutations (that
may affect positively or negatively more than
one viral function), and of coevolution of phe-
notypic traits. However, it may also introduce
additional evolutionary constraints to the virus,
Figure 2. A simpliﬁed view of some events involved in RNA virus transmission, that takes into
consideration that RNAviruses are quasispecies (mutant distributions). A swine-human transmission is used
as illustration. An RNAvirus replicates in an infected swine and it can shed different amounts of virus (a, b, c)
that can reach a susceptible human. If two speciﬁc mutations are needed for the virus to initiate replication in
the exposed human host, only the mutant spectrum that includes the required mutations will be established in
the human host (in this case distribution b). If viral replication continues in the same individual (human ﬁgure
on the right, two time points of the same human depicted as separated by the grey arrow), a new mutant
distribution will be generated, shaped by the selective constraints imposed by each individual human
(immune response and others). Human-to-human transmission (not shown in this scheme) will again involve
bottlenecks of different intensities (number of genomes that reach the successive recipient humans). When
transmissions occur among individuals of the same host species, it is likely that most mutant distributions will
include genomes that are replication-competent in the recipient host. The picture is in reality more complex,
as documented in the text. However, the scheme emphasizes the fact that viruses are not deﬁned sequences
but mutant distributions, and very frequently this pro-adaptive population structure has not been considered
in treatments of emerging viral infections.
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as will the overlap of domains (in viral proteins
or nucleic acids) in general. Structural and bio-
chemical studies have indicated that residues
located at the surface of viral particles tend to
be subjected to less structural constraints than
residues located in the interior of viral capsids
or envelopes and, therefore, they may be prone
to accept amino acid substitutions. Tolerance to
change of surface amino acid residues may
facilitate the emergence of new cell receptor
speciﬁcities mediated by antigenic change with
obvious implications for viral disease emer-
gence and re-emergence [10, 34, 43, 90]. Partial
immunity to FMDV, evoked by synthetic pep-
tides that mimicked the major antigenic site of
the virus, produced the selection of antigenic
variants in cattle, and the variants displayed
alterations of cell tropism [80, 81]. Escape
mutants selected by ineffective vaccines have
been reported in other viral systems [85]. In
addition, tolerance to amino acid substitutions
at surface sites of capsid or envelope proteins
may result in antigenic variation independent
of immune selection, as documented with sev-
eral DNA and RNA viruses [10].
Long-term coexistence of viruses and their
hosts has given coevolution a good chance to
reach some relative equilibrium that has
excluded ‘‘super-virulent’’ pathogens from our
biosphere, because if they existed they would
be eliminated with their hosts. However, tran-
sient disequilibria may often occur when
viruses cross a species barrier. The great major-
ity of viruses are not pathogenic, although most
of the viruses that have been studied in detail
are associated with disease, for obvious reasons.
Many viruses do not cause disease in their nat-
ural reservoir hosts but can be highly patho-
genic when transmitted to a new host species.
This is amply documented by the zoonotic nat-
ure of most of the viruses that have emerged in
the human population (inﬂuenza virus type A
from aquatic birds, HIV-1 from Old World pri-
mates, SARS coronavirus from bats probably
via palm civets, Nipah and Hendra viruses from
fruit bats via pigs, among others) [1, 33, 40, 55,
59, 69, 77, 89].
Population equilibria and disequilibria in
viruses depend also on the nature and tempo
of genetic change imposed by the surrounding
host environments, in ways that only now we
are beginning to understand.
5. SOME GENERAL CONCLUSIONS
ON VIRAL DISEASE EMERGENCE.
ZOONOTIC RESERVOIRS
AND FITNESS GAINS
Viruses generally have multiple genes
involved in cellular tropism and host range, that
encode non-structural or structural viral proteins
[2, 51]. Modiﬁcation of such genes by mutation
or their acquisition by recombination or reas-
sortment opens the way to a change in host
range and to disease emergence. In the present
article I have emphasized a major issue of
RNA virus genetics that has been considered
only marginally in several studies on the mech-
anisms of viral disease emergence. The issue is
that RNA viruses replicate as complex mutant
distributions, termed viral quasispecies, and that
the complexity and composition of mutant dis-
tributions are key factors in virus adaptation and
persistence [13, 14, 16, 23, 70, 73, 84] (Tab. I).
Contrary to designed experiments of adaptation
of a virus to new host in which the role of
mutant spectra in the adaptation process has
been observed [64], no such observations have
been made in the process of a natural emer-
gence. Therefore, there is no deﬁnitive proof
that a number of related mutants from a donor
host reached a potential new host, or that
genetic variation of the colonizing virus was
essential for the establishment of the virus in
the new host. However, what the molecular
studies on viral genomes tell us is that when
more than one virus particle reaches a recipient
host there is a high probability that the genomes
will not be identical, and that they may display
ﬁtness differences. It is worth noting that ﬁtness
changes can occur in viral quasispecies without
being reﬂected in any modiﬁcation of the geno-
mic consensus nucleotide sequence [30–32].
Thus, relevant biological information can
be lost if surveys of viral genomic sequences
(for the purpose of the control of disease emer-
gence or other), are restricted to the determina-
tion of consensus sequences. A new era to
penetrate into the mutant spectrum composition
Vet. Res. (2010) 41:38 E. Domingo
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has started with the use of the new ultra deep
sequencing or microarray-based methodologies
by which the characterization of mutant spectra
can be based on thousands of sequences
[20, 47, 82, 86, 88].
Despite difﬁculties of implementation, it
would be important to survey those viruses that
have manifested a potential for emergence in
the human population (human and animal inﬂu-
enza viruses, animal coronaviruses, primate len-
tiviruses, animal picornaviruses, etc.) not only
by sampling consensus sequences but also by
ultra deep sequencing. However, for obvious
reasons covered in this and other articles of this
special issue, it is not possible to anticipate
which viruses from the multiple animal reser-
voirs are going to emerge as new human patho-
gens and when. Survey of the circulating
zoonotic viruses, with effective communica-
tions networks, the development of new vac-
cines and antiviral agents, and an increasing
understanding of viral population dynamics all
should contribute to either delaying viral emer-
gences or reducing their impact once they
occur.
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